Literature DB >> 27797769

Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.

Hai Yang1,2, Qiang Wei1,2, Xue Zhong2,3, Hushan Yang4, Bingshan Li1,2.   

Abstract

Motivation: Comprehensive catalogue of genes that drive tumor initiation and progression in cancer is key to advancing diagnostics, therapeutics and treatment. Given the complexity of cancer, the catalogue is far from complete yet. Increasing evidence shows that driver genes exhibit consistent aberration patterns across multiple-omics in tumors. In this study, we aim to leverage complementary information encoded in each of the omics data to identify novel driver genes through an integrative framework. Specifically, we integrated mutations, gene expression, DNA copy numbers, DNA methylation and protein abundance, all available in The Cancer Genome Atlas (TCGA) and developed iDriver, a non-parametric Bayesian framework based on multivariate statistical modeling to identify driver genes in an unsupervised fashion. iDriver captures the inherent clusters of gene aberrations and constructs the background distribution that is used to assess and calibrate the confidence of driver genes identified through multi-dimensional genomic data.
Results: We applied the method to 4 cancer types in TCGA and identified candidate driver genes that are highly enriched with known drivers. (e.g.: P < 3.40 × 10 -36 for breast cancer). We are particularly interested in novel genes and observed multiple lines of supporting evidence. Using systematic evaluation from multiple independent aspects, we identified 45 candidate driver genes that were not previously known across these 4 cancer types. The finding has important implications that integrating additional genomic data with multivariate statistics can help identify cancer drivers and guide the next stage of cancer genomics research. Availability and Implementation: The C ++ source code is freely available at https://medschool.vanderbilt.edu/cgg/ . Contacts: hai.yang@vanderbilt.edu or bingshan.li@Vanderbilt.Edu. Supplementary information: Supplementary data are available at Bioinformatics online.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com

Entities:  

Mesh:

Year:  2017        PMID: 27797769      PMCID: PMC6075201          DOI: 10.1093/bioinformatics/btw662

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  42 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Somatic mutations of the protein kinase gene family in human lung cancer.

Authors:  Helen Davies; Chris Hunter; Raffaella Smith; Philip Stephens; Chris Greenman; Graham Bignell; Jon Teague; Adam Butler; Sarah Edkins; Claire Stevens; Adrian Parker; Sarah O'Meara; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Jody Clements; Jennifer Cole; Ed Dicks; Ken Edwards; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; Rebecca Shepherd; Alexandra Small; Helen Solomon; Yvonne Stephens; Calli Tofts; Jennifer Varian; Anthony Webb; Sofie West; Sara Widaa; Andrew Yates; Francis Brasseur; Colin S Cooper; Adrienne M Flanagan; Anthony Green; Maggie Knowles; Suet Y Leung; Leendert H J Looijenga; Bruce Malkowicz; Marco A Pierotti; Bin T Teh; Siu T Yuen; Sunil R Lakhani; Douglas F Easton; Barbara L Weber; Peter Goldstraw; Andrew G Nicholson; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

Review 3.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

4.  CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.

Authors:  Z Liu; X Yang; Z Li; C McMahon; C Sizer; L Barenboim-Stapleton; V Bliskovsky; B Mock; T Ried; W B London; J Maris; J Khan; C J Thiele
Journal:  Cell Death Differ       Date:  2011-01-21       Impact factor: 15.828

Review 5.  Future of personalized medicine in oncology: a systems biology approach.

Authors:  Ana Maria Gonzalez-Angulo; Bryan T J Hennessy; Gordon B Mills
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

6.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 7.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

8.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013.

Authors:  Jing Wang; Dexter Duncan; Zhiao Shi; Bing Zhang
Journal:  Nucleic Acids Res       Date:  2013-05-23       Impact factor: 16.971

9.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

10.  A framework for the interpretation of de novo mutation in human disease.

Authors:  Kaitlin E Samocha; Elise B Robinson; Stephan J Sanders; Christine Stevens; Aniko Sabo; Lauren M McGrath; Jack A Kosmicki; Karola Rehnström; Swapan Mallick; Andrew Kirby; Dennis P Wall; Daniel G MacArthur; Stacey B Gabriel; Mark DePristo; Shaun M Purcell; Aarno Palotie; Eric Boerwinkle; Joseph D Buxbaum; Edwin H Cook; Richard A Gibbs; Gerard D Schellenberg; James S Sutcliffe; Bernie Devlin; Kathryn Roeder; Benjamin M Neale; Mark J Daly
Journal:  Nat Genet       Date:  2014-08-03       Impact factor: 38.330

View more
  9 in total

1.  De novo pattern discovery enables robust assessment of functional consequences of non-coding variants.

Authors:  Hai Yang; Rui Chen; Quan Wang; Qiang Wei; Ying Ji; Guangze Zheng; Xue Zhong; Nancy J Cox; Bingshan Li
Journal:  Bioinformatics       Date:  2019-05-01       Impact factor: 6.937

2.  DriveWays: a method for identifying possibly overlapping driver pathways in cancer.

Authors:  Ilyes Baali; Cesim Erten; Hilal Kazan
Journal:  Sci Rep       Date:  2020-12-15       Impact factor: 4.379

3.  Identification of RPL5 gene variants and the risk of hepatic vein thrombosis in Saudi patients.

Authors:  Fathelrahman M Hassan; Afnan A Alsultan; Faisal Alzahrani; Waleed H Albuali; Dalal K Bubshait; Elfadil M Abass; Mudathir A Elbasheer; Abdulmohsen A Alkhanbashi
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

4.  A novel network regularized matrix decomposition method to detect mutated cancer genes in tumour samples with inter-patient heterogeneity.

Authors:  Jianing Xi; Ao Li; Minghui Wang
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

5.  Discovering mutated driver genes through a robust and sparse co-regularized matrix factorization framework with prior information from mRNA expression patterns and interaction network.

Authors:  Jianing Xi; Minghui Wang; Ao Li
Journal:  BMC Bioinformatics       Date:  2018-06-05       Impact factor: 3.169

6.  Systematic discovery of the functional impact of somatic genome alterations in individual tumors through tumor-specific causal inference.

Authors:  Chunhui Cai; Gregory F Cooper; Kevin N Lu; Xiaojun Ma; Shuping Xu; Zhenlong Zhao; Xueer Chen; Yifan Xue; Adrian V Lee; Nathan Clark; Vicky Chen; Songjian Lu; Lujia Chen; Liyue Yu; Harry S Hochheiser; Xia Jiang; Q Jane Wang; Xinghua Lu
Journal:  PLoS Comput Biol       Date:  2019-07-05       Impact factor: 4.475

7.  An Effective Graph Clustering Method to Identify Cancer Driver Modules.

Authors:  Wei Zhang; Yifu Zeng; Lei Wang; Yue Liu; Yi-Nan Cheng
Journal:  Front Bioeng Biotechnol       Date:  2020-04-07

8.  Ranking cancer drivers via betweenness-based outlier detection and random walks.

Authors:  Cesim Erten; Aissa Houdjedj; Hilal Kazan
Journal:  BMC Bioinformatics       Date:  2021-02-10       Impact factor: 3.169

9.  Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma.

Authors:  Kaishan Tao; Zhenyuan Bian; Qiong Zhang; Xu Guo; Chun Yin; Yang Wang; Kaixiang Zhou; Shaogui Wan; Meifang Shi; Dengke Bao; Chuhu Yang; Jinliang Xing
Journal:  EBioMedicine       Date:  2020-06-05       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.